 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/11/2017 |
$7.70 |
$7.80 |
$7.45 |
$7.55 |
215.80K | | 08/14/2017 |
$7.60 |
$7.65 |
$7.25 |
$7.40 |
350.00K | | 08/15/2017 |
$7.20 |
$8.45 |
$7.01 |
$8.10 |
833.10K | | 08/16/2017 |
$8.15 |
$8.84 |
$7.96 |
$8.50 |
683.30K | | 08/17/2017 |
$8.40 |
$9.01 |
$8.05 |
$8.15 |
608.20K |
|
|
| Abeona Therapeutics is a clinical stage biopharmaceutical company developing gene therapies for life-threatening rare genetic diseases. Co.'s primary programs are ABO-102 and ABO-101, adeno-associated virus based gene therapies for Sanfilippo syndrome. Co. also develops EB-101, gene-corrected skin grafts for recessive dystrophic epidermolysis bullosa; EB-201 for epidermolysis bullosa; ABO-201, gene therapy for juvenile Batten disease; ABO-202 gene therapy for treatment of infantile Batten disease; ABO-301 for Fanconi anemia disorder; and ABO-302 for rare blood diseases. Co. has a plasma-based protein therapy platform, using its proprietary SDFTM (Salt Diafiltration) ethanol-free process. |
|
|
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on August 11, 2017, ABEO opened at $7.70, traded as high as $7.80 and as low as $7.45, and closed at $7.55. Trading volume was a total of 215.80K shares. On August 14, 2017, ABEO opened at $7.60, traded as high as $7.65 and as low as $7.25, and closed at $7.40. Trading volume was a total of 350.00K shares. On August 15, 2017, ABEO opened at $7.20, traded as high as $8.45 and as low as $7.01, and closed at $8.10. Trading volume was a total of 833.10K shares. On August 16, 2017, ABEO opened at $8.15, traded as high as $8.84 and as low as $7.96, and closed at $8.50. Trading volume was a total of 683.30K shares. On August 17, 2017, ABEO opened at $8.40, traded as high as $9.01 and as low as $8.05, and closed at $8.15. Trading volume was a total of 608.20K shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/20/2007 |
|
| End date: |
08/17/2017 |
|
| Start price/share: |
$3.40 |
|
| End price/share: |
$8.15 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
139.71% |
|
| Average Annual Total Return: |
9.14% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$23,979.47 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 08/11/2017 | $7.55 | | 08/14/2017 | $7.40 | | 08/15/2017 | $8.10 | | 08/16/2017 | $8.50 | | 08/17/2017 | $8.15 |
|
|
